Search results for 'American Epilepsy Society'
NeuroPace announces clinical trial results demonstrating the RNS System
NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS- System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication.
http://www.news-medical.net/news/20091209/NeuroPace-announces-clinical-trial-results-demonstrating-the-RNS-System.aspx
NeuroPace's RNS System effective for controlling seizures not treatable by medication in epilepsy patients
NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication.
http://www.news-medical.net/news/20091208/NeuroPaces-RNS-System-effective-for-controlling-seizures-not-treatable-by-medication-in-epilepsy-patients.aspx
UCB presents data on Vimpat AED at AES meeting
UCB today announced new findings on its antiepileptic drug (AED) Vimpat® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking Vimpat® for up to three years, and a consistent long-term tolerability profile.
http://www.news-medical.net/news/20091207/UCB-presents-data-on-Vimpat-AED-at-AES-meeting.aspx
Neuroscientists show how brain waves can be used to perform certain tasks
Neuroscientists at the Mayo Clinic campus in Jacksonville, Fla., have demonstrated how brain waves can be used to type alphanumerical characters on a computer screen. By merely focusing on the "q" in a matrix of letters, for example, that "q" appears on the monitor.
http://www.news-medical.net/news/20091207/Neuroscientists-show-how-brain-waves-can-be-used-to-perform-certain-tasks.aspx
DBS therapy offers hope for epilepsy patients
Long-term data from an investigational study of Deep Brain Stimulation (DBS) Therapy for Epilepsy was released this week by Medtronic, Inc. (NYSE:MDT) at the American Epilepsy Society Meeting (AES) in Boston.
http://www.news-medical.net/news/20091207/DBS-therapy-offers-hope-for-epilepsy-patients.aspx
AES: Progress in epilepsy management not reached millions of people around the world
Substantial progress has been made over the last 15 years in the healthcare community's ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy management has not reached most of the 50 million people around the world, including many of the nearly three million people in the United States who have the disorder.
http://www.news-medical.net/news/20091205/AES-Progress-in-epilepsy-management-not-reached-millions-of-people-around-the-world.aspx
Health experts address treatment gap in epilepsy management at AES Annual Meeting
Substantial progress has been made over the last 15 years in the healthcare community's ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy management has not reached most of the 50 million people around the world, including many of the nearly three million people in the United States who have the disorder.
http://www.news-medical.net/news/20091205/Health-experts-address-treatment-gap-in-epilepsy-management-at-AES-Annual-Meeting.aspx
Cyberonics' FDA-approved VNS Therapy to be featured at the AES meeting
Cyberonics, Inc. announced today that Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, will be featured in 14 presentations at the American Epilepsy Society's (AES) Annual Meeting, taking place December 4-8 at the Hynes Convention Center in Boston, Massachusetts.
http://www.news-medical.net/news/20091204/Cyberonics-FDA-approved-VNS-Therapy-to-be-featured-at-the-AES-meeting.aspx
Analysis explores the importance of CNS-related conditions and their impact on epilepsy management
Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur more often in people who said they had been diagnosed with epilepsy versus those without an epilepsy diagnosis, according to a survey of approximately 173,000 households across the U.S.
http://www.news-medical.net/news/20091204/Analysis-explores-the-importance-of-CNS-related-conditions-and-their-impact-on-epilepsy-management.aspx
Sepracor to present clinical study data of STEDESA at the 2009 AES meeting
Sepracor Inc. today announced that clinical study data for STEDESA™ (eslicarbazepine acetate) will be presented at the 2009 annual meeting of the American Epilepsy Society (AES) in Boston. Seven posters describing new safety analyses will be presented at the Hynes Convention Center during the formal poster session on Saturday, December 5, 2009 between 1:00 pm and 8:00 pm EST.
http://www.news-medical.net/news/20091202/Sepracor-to-present-clinical-study-data-of-STEDESA-at-the-2009-AES-meeting.aspx
Findings in epilepsy gene in animals may guide treatment directions for infants
Researchers studying a difficult-to-treat form of childhood epilepsy called infantile spasms have developed a line of mice that experiences seizures with features closely resembling those occurring in patients with infantile seizures. These genetically engineered mice provide a new opportunity for scientists to test treatments that may benefit children.
http://www.news-medical.net/news/20090601/Findings-in-epilepsy-gene-in-animals-may-guide-treatment-directions-for-infants.aspx
Women with epilepsy should avoid taking the drug valproate during pregnancy
New guidelines developed by the American Academy of Neurology and the American Epilepsy Society show it's relatively safe for women with epilepsy to become pregnant, but caution must be taken, including avoiding one particular epilepsy drug that can cause birth defects.
http://www.news-medical.net/news/2009/04/27/48909.aspx
Doctors question FDA suicide alert on anticonvulsant drugs
Medical specialists at the nation's largest professional meeting on epilepsy discussed multiple questions and concerns they have about data presented by the FDA in support of its recent suicide alert on anticonvulsant drugs (AEDs) and the potential effect of the federal agency's analyses on clinical practice and the way AED drug trials are to be conducted in the future.
http://www.news-medical.net/news/2008/12/10/43977.aspx
First comprehensive look at treatment practices for nonepileptic seizures
A new nationwide clinician survey provides the first comprehensive look at what is community care or 'treatment as usual' for nonepileptic seizures (NES), laying the groundwork for clinical trials aimed at identifying effective treatments for this neuropsychiatric disorder.
http://www.news-medical.net/news/2008/04/21/37575.aspx
Research yields new epilepsy guidelines
In conjunction with the AMA, the American Academy of Neurology and the American Epilepsy Society on April 26 jointly announced new guidelines for treating epilepsy. The number of anti-epileptic drugs has more than doubled in the last decade.
http://www.news-medical.net/news/2004/04/26/864.aspx
News-Medical.Net provides this medical information service in accordance
with these
terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.
Subscribe